This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Cryoport, Inc., the leading provider of advanced cryogenic logistics
solutions for the life sciences industry, serving markets including
immunotherapies, stem cells, cell lines, clinical research organizations,
vaccine manufacturers, animal health, and reproductive medicine, today
announced that it has been selected by Lynden International as
its preferred provider to support cold chain clinical trial logistics for
underrepresented diseases in Africa.
Cryoport's comprehensive cryogenic logistics solutions will complement
Lynden's cold chain capabilities in support of its shipments of
temperature sensitive materials for ongoing clinical trials in Africa.
Cryoport's solutions ensure that the integrity of shipments and content
are maintained and enable more efficient results through greater safety
and speed of delivery. Cryoport's global network allows shipments to
securely reach remote locations that are part of this clinical trial.
Lynden International is a full-service domestic and international freight
forwarder with over 50 offices worldwide, including the United States,
Micronesia, Canada, Mexico, Brazil, Russia and the Russian Far East.
Lynden serves as a trusted partner to a wide variety of companies in
varying industries including healthcare and pharmaceuticals.
Jerrell Shelton, Chief Executive Officer of Cryoport, commented, "We are
pleased with the opportunity to expand Lynden's capabilities with our
validated cryogenic logistics solutions. We have great experience in
clinical trial logistics and look forward to working with Lynden in
furthering clinical trial work in Africa for underrepresented diseases.
Our best-in-class cryogenic logistics solutions are a key component to
providing the worldwide access that is required by the life science
industry to successfully conduct clinical trials around the globe."
For more information, click here.
